Zevra’s Arimoclomol US FDA Panel Nod Includes Nonclinical Data Doubts

 
• By Sue Sutter
Confirm
Zevra's nonclinical data cannot provide confirmatory evidence. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers